Articles
HollisterStier Contract Manufacturing Completes Qualification Of New Small Volume Parenterals (SVP) Line 2
May 13, 2008
HollisterStier Laboratories is continuing expansion on their 172,000 ft2 state-of-the-art facility to include a new Small Volume Parenterals (SVP) line, available to aseptically fill liquid and lyophilized pharmaceutical products in vials ranging from 2mL through 200 mL in batch sizes from 20 to 3,000 liters.
The new line (SVP II) houses a vial filling complex encompassing 25,500 ft2 with a Bosch FLC 3080 vial filler equipped with a nondestructive automatic check weigh system, diaphragm filling pumps and speeds up to 400 vpm. The line offers multiple options for compounding including aseptic compounding, portable compounding vessels, and large fixed compounding tanks. The vial inspection and packaging area includes inspection, labeling, Ink Jet coding and secondary packaging.
SVP II is designed for multi-product manufacturing, both commercial and clinical trial material, with one product manufactured in the area at a time. SVP II is benefited further by the advances in pharmaceutical technology such as automated non-destructive fill checks and ISO5 oversealing.
"The expansion of our facilities is a reflection of the successes that our organization has worked hard to achieve" said Anthony Bonanzino Ph.D., CEO of HollisterStier Laboratories. "We take pride in the quality and efficiency we provide our customers. Our reputation as world-class contract manufacturers has allowed for us to be in a position to expand upon our capabilities so that we can continue to best serve our customer-base." Construction of SVP II began in 2007 and underwent validation and media fills in early 2008. Two GEA Lyophilizers will be added in a new ISO5/6 facility and ready for production in Q1 2009.
About HollisterStier Contract Manufacturing
HollisterStier Laboratories are experts in the contract manufacture of high-quality sterile injectables for the global pharmaceutical and biopharmaceutical market. Multidisciplinary teams provide custom solutions to customer-specific project goals from development through commercialization. Founded in 1921 and based in Spokane, Washington, HollisterStier is committed to meeting customer expectations in all aspects of business from quality manufacturing to regulatory support. The company has leading pharmaceutical, generic, and biotechnology companies as its customers. HollisterStier Laboratories LLC is owned by Jubilant Organosys Ltd. For further information about HollisterStier contract manufacturing, visit www.fill.hollisterstier.com and for Jubilant Organosys, www.jubl.com.
